Elevated Polyreactive Immunoglobulin G in Immune‐Mediated Liver Injuries With the Need for Immunosuppressive Therapy
Liver International · 2026
DOI: 10.1111/liv.70571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Theresa Kirchner und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Hepatitis, Autoimmune, Chemical and Drug Induced Liver Injury, Immunoglobulin G, Immunosuppressive Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Else Kröner-Fresenius-Stiftung, Niedersächsisches Ministerium für Wissenschaft und Kultur.
Abstract (Originalsprache)
Background & Aims The distinction of drug‐induced liver injury (DILI), drug‐induced autoimmune‐like hepatitis (DI‐ALH), and autoimmune hepatitis (AIH) can be challenging due to overlapping clinical characteristics. Recently, polyreactive immunoglobulin G (pIgG) was identified as a novel biomarker in AIH. This retrospective study aimed to evaluate the diagnostic accuracy of pIgG to distinguish between AIH, DI‐ALH, and DILI and thus identify patients in need of immunosuppression.
Methods
Samples from 120 patients (AIH = 81, DI‐ALH = 16, DILI = 23) were compared to a control group (non‐AIH‐non‐DILI‐liver disease = 596 and healthy controls = 190).
Results
No patient in the DILI‐group but 98% in the AIH‐ and 94% in the DI‐ALH‐group received immunosuppressive treatment. PIgG levels were significantly higher in the AIH‐group 1.9 normalised arbitrary units (nAU) compared to DILI (1.1 nAU, p < 0.001), non‐AIH‐non‐DILI‐LD (1.0 nAU, p < 0.001) and healthy controls (0.27 nAU, p < 0.001). PIgG levels for DI‐ALH (1.7nAU) were significantly higher compared to DILI ( p = 0.044) and non‐AIH‐non‐DILI‐LD and healthy controls (both p < 0.001). Highest AUC was seen for pIgG (0.818) compared to conventional autoantibodies. The overall accuracy of pIgG to distinguish AIH from DILI (74%) and liver injuries with and without the need for immunosuppression (73%) was like that of ANA (71%/73%) and SMA (74%/69%) at cut‐offs of ≥ 1/40. PIgG was positive in up to 79% of patients with AIH that were negative for a conventional autoantibody and was positive in 90% of DI‐ALH cases compared to 25% in DILI that were caused by the same drugs.
Conclusions
PIgG may complement current serologic tests to identify patients with liver injury in need of immunosuppressive treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
- European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany.
- Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece.
- Unidad de Gestión Clínica de Aparato Digestivo, Instituto de Investigación Biomédica de Málaga-IBIMA, Plataforma BIONAND, CIBEREHD, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain.
- Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
- Department of Hepatology, Transplantology, Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
ORCID-Profile: Mercedes Robles-Díaz, Raúl J Andrade, Ansgar Lohse, Mirjam Kolev, Tom Jg Gevers, Heiner Wedemeyer
Förderung
- Deutsche Forschungsgemeinschaft
- Else Kröner-Fresenius-Stiftung
- Niedersächsisches Ministerium für Wissenschaft und Kultur
Zitieren
APA
Kirchner, T., Dalekos, G. N., Zachou, K., Robles-Díaz, M., Andrade, R. J., Sebode, M., Lohse, A., Janik, M. K., Milkiewicz, P., Kolev, M., Semmo, N., Bruns, T., Gevers, T. J., Beretta-Piccoli, B. T., Wedemeyer, H., Jaeckel, E., Taubert, R., Engel, B., & pIgG study group (2026). Elevated Polyreactive Immunoglobulin G in Immune‐Mediated Liver Injuries With the Need for Immunosuppressive Therapy. Liver International. https://doi.org/10.1111/liv.70571
Vancouver
Kirchner T, Dalekos GN, Zachou K, Robles-Díaz M, Andrade RJ, Sebode M, et al. Elevated Polyreactive Immunoglobulin G in Immune‐Mediated Liver Injuries With the Need for Immunosuppressive Therapy. Liver International. 2026. doi:10.1111/liv.70571
BibTeX
@article{Kirchner2026,
author = {Kirchner, Theresa and Dalekos, George N and Zachou, Kalliopi and Robles-Díaz, Mercedes and Andrade, Raúl J and Sebode, Marcial and Lohse, Ansgar and Janik, Maciej K and Milkiewicz, Piotr and Kolev, Mirjam and Semmo, Nasser and Bruns, Tony and Gevers, Tom Jg and Beretta-Piccoli, Benedetta Terziroli and Wedemeyer, Heiner and Jaeckel, Elmar and Taubert, Richard and Engel, Bastian and pIgG study group, pIgG study group},
title = {Elevated Polyreactive Immunoglobulin G in Immune‐Mediated Liver Injuries With the Need for Immunosuppressive Therapy},
journal = {Liver International},
year = {2026},
doi = {10.1111/liv.70571}
}
EUVIMED